Assessing the Efficacy of Passive Exoskeletons for Construction Work: Lab-Based Study

September 22, 2020 updated by: Xiang Yang, University of Arizona
This project aims to assess the effectiveness and acceptability of four types of commercial Back support exoskeletons (BSEs) for concrete work tasks. BSEs are external wearable devices designed to reduce physical demands on the back by providing assistive moments to body joints to support muscles. There is considerable evidence to suggest such exoskeletons reduce the risks of back injuries for workers performing repetitive tasks. However, since the effects of using BSEs in concrete work tasks are still unknown, evidence-based information regarding effectiveness, productivity impact, and safety risks is required to help industries adopt BSEs as an ergonomic intervention.

Study Overview

Detailed Description

The experimental protocol will require approximately 3 hours of the participant's time. It will be comprised of six stages:

Stage I: Body Discomfort and Handedness Questionnaires First, the research team will administer an interview questionnaire to the participant to obtain information on participants' body pain/discomfort level and to determine the participant's hand dominance using the Edinburgh Handedness Inventory.

Stage II: Anthropometric body measurements and strength testing Several anthropometric body dimensions will be measured in the standing upright position using a standard tape measure and anthropometer. Body measurements will include standing height, shoulder height, waist to floor height, leg length, knee height, upper and lower arm length, foot length, and inter shoulder distance. Study participants' body weight will be measured using a standard weighing scale. Maximum power grip strength on both hands will be measured for 3 trials using a standard hand-held grip dynamometer.

Stage III: Fitting BSEs Four types of commercial BSEs (backX, Laevo 2, FLx ErgoSkeleton, V22 ErgoSkeleton) will be introduced to participants. Following manufacturers' instructions, participants will be allowed to test each device, fit the device to their body for comfort by using adjustable features (e.g., straps).

Stage IV: Optical motion capture marker, wearable inertial sensors, and surface electromyography (sEMG) sensor placement A commercial motion-capture system (Qualisys AB, Kvarnbergsgatan, Göteborg, Sweden) will be used to monitor and analyze body segment motion trajectories in a three-dimensional space. Several optical markers will be placed on anatomical landmarks of study participants including the head, shoulders, arms, hands, back, pelvis, legs, and feet. Hypo-allergenic double-sided tape will be used to attach the optical markers to the anatomical landmarks. Wearable inertial sensors will be attached using hypoallergenic double-sided tape at the low-back near the waist (S1), upper back (T6), sternum, upper arm (R, L), lower arm (R, L), thigh (R, L), and shank (R, L). Eight sEMG sensors will be placed on Descending Trapezius (TRP), Anterior Deltoid (AD), Iliocostalis Lumborum (ILL), Rectus Abdominis (RA), External Oblique (EO), Cervical Erector Spinae (CES), Latissimus Dorsi (LD), and Vastus Lateralis (VL) to measure muscle activation level while performing simulated work tasks, which are described in Stage VI.

Stage V: Maximum Voluntary Contraction (MVC) measurement for muscle activation While performing work tasks, muscle activation level varies between muscles and between subjects. A common way is to normalize myoelectric activities of each muscle for every participant by measuring isometric Maximal Voluntary Contraction (MVC). In this study, the investigators will measure 11 MVCs before the start of actual work tasks. Our MVC tests will be based on a study of trunk muscles. Before the MVC measurement, participants will be asked to warm up by 5 stretch exercises: (a) Stand upright with his feet shoulder-width apart. Place his hands on his buttocks for support. Look upwards and slowly lean backward. Keep his legs sturdy. (b) Stand upright with his feet shoulder-width apart. Place one hand on his buttocks for support. Look up and slowly lean backward. Reach over with his opposite hand. Rotate the upper body at the waist. (c) Kneel on one foot. Place his hands on his hips. Push hips forward. If necessary, hold on to something to keep balance. (d) Stand upright with his feet shoulder-width apart. Cross his arms and place his hands on shoulders. Slowly rotate his shoulders to one side. To increase the intensity of this stretch, use his hands to help rotate sideways. (e) Kneel on all fours. Support himself with one hand and reach towards his ankle with the other. Keep his back parallel to the ground. Keep the back straight, parallel to the ground, and his thigh in a vertical position. Distribute his weight evenly on both hands and knees. After the warm-up, the MVC testing will be performed, which includes (1) upper trunk flexion: subject will be in a sit-up posture positioned on a bench with the legs bent and feet strapped down with a belt. He then will attempt to flex the upper trunk in the sagittal plane while her thorax will be manually braced by the experimenter; (2) upper trunk twisting (R and L): In the same sitting supported position, the subject will attempt to twist the upper trunk in the horizontal plane while his thorax will be manually braced by the experimenter;(3) lower trunk flexion: subject will attempt to flex the lower trunk in the sagittal plane while he will be in a supine laying position, but with knees and hips both bent to approximately 90 degrees. His thorax will be strapped down with a belt and his legs will be manually braced by the experimenter; (4) lower trunk twisting (R and L): In the same lying and supported position, the subject will attempt to twist the lower trunk in the horizontal plane while his legs will be manually braced by the experimenter;(5) upper trunk bending (R and L): subject will attempt to side bend the upper trunk in the frontal plane while he will be in a side-lying position, with the knees bent and strapped with a belt, and thorax and arms will be manually braced by the experimenter; (6) lower trunk bending: subject will maintain a right and left side bridge position while maximally resisted downward pressure on the pelvis will be applied by the experimenter;(7) upper trunk extension: subject will be strapped in a prone position, with the torso horizontally cantilevered over the end of the bench (Biering-Sorensen position). He will then attempt to extend the upper trunk in the sagittal plane and retract the shoulders (squeezing the scapulae together) while manual resistance will be applied on the shoulders by the experimenter; (8) lower trunk extension: subject will attempt to extend the lower trunk and the hips against manual resistance when in a prone position, with the torso on the bench and the legs horizontally cantilevered over the end of the bench; (9) shoulder rotation and adduction (R and L): subject will attempt to adduct and internally rotate the shoulder against manual resistance with the shoulder abducted and elbow flexed, both to 90 degrees. In addition, two unresisted maximal abdominal contractions will be performed in standing; (10) maximal effort abdominal hollowing: subject will attempt to maximally activate the deep abdominal muscles while drawing in the lower abdomen; (11) maximal effort abdominal bracing: subject will attempt to maximally activate all the abdominal wall without any change in the position of the muscles. In all MVC testing, participants will be asked to exert their maximum force at a static posture (instructions will be given by our researcher) for every five seconds. For the first two seconds, they will be asked to ramp up to their maximum and maintain the force for the next three seconds. MVCs will be tested at least two times for each muscle group.

Stage VI: Data collection in simulated construction work tasks Postural data will be recorded from participants while performing six simulated concrete work tasks (i.e., shoveling, framing, carrying and lifting of construction materials, hammering, and tying rebars) at different intensities. The material they will be lifting, carrying, shoveling, and holding will not go over the safety limit of 30 lbs, as stated by NIOSH. Participants will perform the tasks with vs. without wearing different BSEs. Task trials will be video recorded for visual correspondence when analyzing motion capture and inertial sensor data. Participants will be given two minutes rest break between tasks and thirty seconds rest break between trials. The order of task conditions within each work task will be randomized.

  • Task 1: Shoveling and moving construction material from location A to B. Distance between A and B will be set to 0.5m, both located at the ground level. Participants will be asked to shovel construction materials with three different weights (i.e., dirt, cement, and gravel). Participants will be asked to shovel at a high-frequency rate (15 scoops per minute).
  • Task 2: Framing 30" wall using a power screwdriver. The frame will be placed on the floor, versus an elevated surface (28" height). Participants will be asked to use a power screwdriver to drive a screw into and out of the frame.
  • Task 3: Carrying construction materials of different weights (i.e., wood frames and pipes) for up to 10 meters in each trial. The maximum weight of the carried materials will not exceed 30 lbs.
  • Task 4: Lifting construction materials of different weights. The same materials will be used as the carrying task.
  • Task 5: Pounding a punching bag located in the ground vs. 18 inches high vs. 36 inches high using a sledgehammer of different weights (i.e., 0, 6, 12, 16, and 20 lbs.).
  • Task 6: Tying rebar in a framed grid located on different height levels (i.e., 0", 50").

The tasks and intensity levels were selected to be diverse yet reproducible (in terms of body postures) and resemble common tasks encountered in concrete work tasks.

Participants will be asked to answer questionnaires asking their experience, usability, and acceptability on each exoskeleton after they complete each work task.

The data collection process will end with removing optical markers and wearable sensors. Participants will be offered a rest break and refreshment if needed and followed by compensation and completing the payment form.

Study Type

Interventional

Enrollment (Anticipated)

25

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Be at least 18 years old.
  • Be able to walk and/or lift heavy objects without pain/discomfort.

Exclusion Criteria:

  • Have prior back/neck injuries or chronic pain in the last 6 months.
  • Have a pacemakers.
  • Have breast implants.
  • Have removed the axillary lymph nodes.
  • Pregnant women.
  • Using blood thinning medications.
  • Participants must consult a physician prior to participating this study if any of the following occurred before or during use: Inguinal hernia, hernia, knee injury hip/knee prosthesis, hyperextended knee, recent surgery, skin disease/injury, scars, inflammation, skin reddening.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Exoskeleton
To compare the efficacy of four different exoskeleton devices, all participants will be asked to finish simulated construction tasks with each exoskeleton. Additionally, all participants will be asked to finish the same tasks without wearing an exoskeleton for reference.
The Laevo V2 is a wearable chest and back support exoskeleton. The Laevo transfers the from its chest pad to the thighs while bending forward. The passive exoskeleton (works with gas springs, not motors) transfers part of the load away from the back muscles, reducing the pressure on the spinal column. It provides a dampening effect on the back, reducing the risk of sudden back muscle contractions that needlessly overcompress the spine.
backX is a novel industrial exoskeleton that substantially augments its wearer and reduces the forces and torques on a wearer's lower back region (L5/S1 disc) by an average of 60% while the wearer is stooping, lifting objects, bending or reaching. backX augments the wearer's strength and can reduce the risk of back injuries among workers. It does not require external motors or power source. The mechanism of backX is similar to the first device "Laevo 2".
The FLx ErgoSkeleton is a range limiting work vest for physical work use. The FLx naturally reminds the user of the correct posture and lifting techniques while on the job site.

Similar to the FLx ErgoSkeleton, the V22 ErgoSkeleton keeps the position of the human body as to always stay within a safe body posture while lifting or moving heavy objects. The V22 ErgoSkeleton applies pressure to remind the user both during improper lifts and over rotation.

In addition, the V22 ErgoSkeleton comes with two clutch controlled cables to assist in lifting and moving. The cables transfer part of the weight of the object being held directly to the V22 ErgoSkeleton vest, similar to other arm and shoulder support exoskeletons.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Muscle activities while performing simulated construction tasks
Time Frame: From admission to discharge, up to 3 hours
Surface electromyography sensors will be placed on the following muscles of participants: Descending Trapezius (TRP), Anterior Deltoid (AD), Iliocostalis Lumborum (ILL), Rectus Abdominis (RA), External Oblique (EO), Cervical Erector Spinae (CES), Latissimus Dorsi (LD), and Vastus Lateralis (VL). Muscle activities while performing tasks represent the physical workload. Maximum Voluntary Contraction (MVC) technique will be used to normalize the muscle activities for comparison.
From admission to discharge, up to 3 hours
Body segment motions in a three-dimensional space measured by two methods
Time Frame: From admission to discharge, up to 3 hours

Method 1: Wearable inertial sensors will be attached using hypoallergenic double-sided tape at the low-back near the waist (S1), upper back (T6), sternum, upper arm (R, L), lower arm (R, L), thigh (R, L), and shank (R, L). Body segment motions will be used to calculate relative angles, repetition count, duration of postures, which represent the physical workload of tasks.

Method 2: Optical markers will be placed on anatomical landmarks of participants including the head, shoulders, arms, hands, back, pelvis, legs, and feet. The data collected my optical markers are mainly used for calibrating other sensors.

From admission to discharge, up to 3 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective review of workload level and experience using different exoskeleton
Time Frame: From admission to discharge, up to 3 hours

Participants will be asked a set of subjective review questions on a questionnaire with eight sections:

The difficulty of tasks: From "Very Difficult" to "Very Easy". "Easier" means a better outcome.

Effectiveness: From "Very unhelpful" to "Very helpful". More helpful means a better outcome.

Pain/discomfort level: From "Just noticeable" to "Intolerable" for different body locations. Less pain or discomfort means a better outcome.

Acceptability: From "Very Uncomfortable" to "Very Comfortable". More comfortable means a better outcome.

Fit/wearability by himself: From "Very difficult" to "Very easy". Easier means a better outcome.

Preference of using this exoskeleton again and recommending to other people: From "Very unlikely" to "Very likely". More likely means a better outcome.

An overall experience by ranking all exoskeletons: Options include 4 exoskeletons and "No exoskeleton". A higher rank means a better outcome.

Open-ended interview.

From admission to discharge, up to 3 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Xiang Yang, Master, University of Arizona

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

October 1, 2020

Primary Completion (Anticipated)

December 1, 2020

Study Completion (Anticipated)

January 1, 2021

Study Registration Dates

First Submitted

September 4, 2020

First Submitted That Met QC Criteria

September 22, 2020

First Posted (Actual)

September 29, 2020

Study Record Updates

Last Update Posted (Actual)

September 29, 2020

Last Update Submitted That Met QC Criteria

September 22, 2020

Last Verified

September 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 2007820207

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

IPD will not be shared to protect the privacy of participants.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Laevo 2

3
Subscribe